Diamicron 30mg Tablet XR
By Diamicron
Rx
10 Tablet XR in a Strip

Composition
Gliclazide(30mg)

Manufacturer - Serdia Pharmaceuticals India Pvt Ltd
Serdia House, Off Dr. S S Rao Road, Behind M G Hospital Parel, Mumbai 400012

Expires on or after
July, 2025

liver
When using Diamicron 30mg Tablet XR, it is important to be cautious if you have severe liver disease. In such cases, a dose adjustment may be necessary, and it is crucial to consult your doctor before taking this medication. If you have a history of liver diseases or conditions, inform your doctor before starting Loyzide-M 30 XR Tablet 15's. Your doctor may need to adjust your dosage based on the status of your liver health.

kidney
Diamicron 30mg Tablet XR is generally safe for use in patients with kidney disease. It is important to inform your doctor of any history of kidney conditions before taking Loyzide-M 30 XR Tablet 15's as dose adjustments may be necessary. However, individuals with severe kidney disease should not take this medication.

alcohol
It is unsafe to consume alcohol with Diamicron 30mg Tablet XR to avoid unpleasant side-effects. Consult your doctor when consuming alcohol with Diamicron 30mg Tablet XR.

driving
Be cautious when driving while taking Loyzide-M 30 XR Tablet 15's as it may cause hypoglycemia, leading to symptoms such as sleepiness, shivering, palpitations, and sweating that can affect your driving ability. Refrain from driving if experiencing these symptoms.

pregnancy
It is advised not to use Diamicron 30mg Tablet XR during pregnancy as it may be harmful to the developing baby based on animal studies. Your doctor will carefully evaluate the benefits and risks before considering prescribing it. Kindly consult your doctor.

breastfeeding
Caution Diamicron 30mg Tablet XR is considered unsafe while breastfeeding due to potential harm to the baby. Prior consultation with a healthcare provider is advised to determine the suitability of taking Loyzide-M 30 XR Tablet 15's for nursing mothers.
Habit Forming | No |
Chemical Class | Second-generation sulfonylurea derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹84
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025